162 related articles for article (PubMed ID: 38509398)
1. Anti-fungal effects of novel N-(tert-butyl)-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amine derivative and it's in-vitro, in-silico, and mode of action against Candida spp.
Nandhagopal M; Mala R; Somarathinam K; Dhakshinamurthy D; Narayanasamy M; Vijayan P; Shankar MM
Arch Microbiol; 2024 Mar; 206(4):186. PubMed ID: 38509398
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
Cabral ME; Figueroa LI; Fariña JI
Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
[TBL] [Abstract][Full Text] [Related]
3. New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
Campos Péret VA; Reis RCFM; Braga SFP; Benedetti MD; Caldas IS; Carvalho DT; Santana LFA; Johann S; Souza TB
Eur J Med Chem; 2023 Aug; 256():115436. PubMed ID: 37146343
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Keniya MV; Ruma YN; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
[TBL] [Abstract][Full Text] [Related]
5. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
6. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
7. Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of
Madrigal-Aguilar DA; Gonzalez-Silva A; Rosales-Acosta B; Bautista-Crescencio C; Ortiz-Álvarez J; Escalante CH; Sánchez-Navarrete J; Hernández-Rodríguez C; Chamorro-Cevallos G; Tamariz J; Villa-Tanaca L
Microbiol Spectr; 2022 Apr; 10(2):e0164221. PubMed ID: 35377226
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
[TBL] [Abstract][Full Text] [Related]
9. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of 2-chloro-N-phenylacetamide: a new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp.
Diniz-Neto H; Silva SL; Cordeiro LV; Silva DF; Oliveira RF; Athayde-Filho PF; Oliveira-Filho AA; Guerra FQS; Lima EO
Braz J Biol; 2022; 84():e255080. PubMed ID: 35262564
[TBL] [Abstract][Full Text] [Related]
11. New Thiazolyl-triazole Schiff Bases: Synthesis and Evaluation of the Anti-Candida Potential.
Stana A; Enache A; Vodnar DC; Nastasă C; Benedec D; Ionuț I; Login C; Marc G; Oniga O; Tiperciuc B
Molecules; 2016 Nov; 21(11):. PubMed ID: 27879678
[TBL] [Abstract][Full Text] [Related]
12. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
14. Small molecules restore azole activity against drug-tolerant and drug-resistant
Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV
mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546
[TBL] [Abstract][Full Text] [Related]
15. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
16. Novel antifungal triazoles with alkynyl-methoxyl side chains: Design, synthesis, and biological activity evaluation.
Xie F; Hao Y; Li L; Wang R; Bao J; Chi X; Monk BC; Wang T; Yu S; Jin Y; Zhang D; Ni T; Yan L
Eur J Med Chem; 2023 Sep; 257():115506. PubMed ID: 37216811
[TBL] [Abstract][Full Text] [Related]
17. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
18. Loss-of-Function
Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
20. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans.
Mahmoud DE; Faraag AHI; Abu El-Wafa WM
World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
